Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 27(12)2022 Jun 10.
Article in English | MEDLINE | ID: mdl-35744885

ABSTRACT

Non-destructive analysis of chlorpheniramine maleate (CPM), pharmaceutical tablets, and granules was conducted by chemometrics-assisted attenuated total reflectance infrared spectroscopy (ATR-IR). For tablets, an optimum PLSR model with eight latent factors was obtained from area-normalized and standard normal variate (SNV) pretreated ATR-IR spectral data with correlation coefficients (R2) of calibration and cross-validation of 0.9716 and 0.9602, respectively. The model capability for the 42 test set samples was proven with R2 between the reference and model prediction values of 0.9632, and a root-mean-square error of prediction (RMSEP) of 1.7786. The successive PLSR model for granules was constructed from SNV and first derivative pretreated ATR-IR spectral data with two latent factors and correlation coefficients (R2) of calibration and cross-validation of 0.9577 and 0.9450, respectively.


Subject(s)
Chemometrics , Chlorpheniramine , Calibration , Least-Squares Analysis , Spectroscopy, Fourier Transform Infrared/methods , Tablets
2.
Pharmaceutics ; 14(6)2022 Jun 16.
Article in English | MEDLINE | ID: mdl-35745850

ABSTRACT

A medium-chain triglyceride (MCT) oil microcapsule was prepared by spray drying. The effects of the wall-material parameters of wall-to-oil ratio (1:1 to 3:1) and type of wall material (gum arabic (GA), whey protein isolate (WPI), and octenyl succinic anhydride (OSA) starch) on the microcapsules were evaluated. The droplet size, size distribution, viscosity, zeta potential, and stability of the emulsions were measured. The spray-dried powder was characterized by its morphology, yield, encapsulation efficiency, and moisture content. The wall material influenced the characteristics of the emulsions and microcapsules. The formulation with a 2:1 wall-to-oil ratio and OSA starch/maltodextrin as the wall material resulted in a small droplet size (0.177 ± 0.002 µm) with high encapsulation efficiency (98.38 ± 0.01%). This formulation had good physical stability over three months under accelerated conditions. Thus, OSA starch/maltodextrin is an appropriate wall material for encapsulating MCT oil.

3.
BMC Complement Altern Med ; 16: 158, 2016 Jun 01.
Article in English | MEDLINE | ID: mdl-27245046

ABSTRACT

BACKGROUND: The emergence of drug resistant pathogens becomes a crucial problem for infectious diseases worldwide. Among these bacteria, Pseudomonas aeruginosa is one of which highly resists to many currently used drugs and becomes a major concern in public health. Up till now, the search for potential antimicrobial agents has been still a challenge for researchers. METHODS: Broth microdilution assay was used to determine minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of the essential oils and antibiotics against P. aeruginosa. Inhibition activity of the essential oils under vapor condition was examined to obtain the minimum inhibitory dose (MID). Time-kill assay included in this study was performed according to CLSI guideline. Bioautographic assay was used to detect active components of the essential oil. Synergistic effect with currently used antibiotics was further examined by checkerboard assay. RESULTS AND DISCUSSION: In this study, a variety of essential oils were examined for anti-multidrug resistant P. aeruginosa (MDR-PA) activity, of which cinnamon bark oil showed the strongest antimicrobial activity against all clinical-isolated MDR-PA strains with MIC of 0.0562-0.225 % v/v and MBC of 0.1125-1.8 % v/v. Bioautographic results demonstrated that the active compounds of cinnamon bark oil were cinnamaldehyde and eugenol which showed strong inhibitory effect against P. aeruginosa. Interestingly, cinnamaldehyde, a major constituent of cinnamon bark oil, possessed stronger antimicrobial effect to P. aeruginosa than eugenol. Under gaseous condition, cinnamon bark oil and cinnamaldehyde showed antibacterial activity against MDR-PA strains with MID of 0.5-1 mg/L. Moreover, combination of cinnamon bark oil or cinnamaldehyde with currently used antibiotics was further studied by checkerboard assay to examine synergistic interactions on clinically isolated MDR-PA strains. Cinnamon bark oil and cinnamaldehyde combined with colistin demonstrated synergistic rates at 16.7 and 10 %, respectively. CONCLUSION: These results indicated that cinnamon bark oil and cinnamaldehyde might be active natural compounds which could be further examined as alternative treatment for multidrug-resistant P. aeruginosa infection.


Subject(s)
Acrolein/analogs & derivatives , Anti-Infective Agents/pharmacology , Oils, Volatile/pharmacology , Pseudomonas aeruginosa/drug effects , Acrolein/pharmacology , Drug Resistance, Multiple , Drug Synergism , Oils, Volatile/chemistry
4.
Pharm Dev Technol ; 18(4): 821-7, 2013.
Article in English | MEDLINE | ID: mdl-22762545

ABSTRACT

BACKGROUND: Oral peptide and protein drug delivery still remain the area of challenges for pharmaceutical scientists due to their low stability and permeability in gastrointestinal (GI) tract. In this study phospholipid vesicle-bound lysozyme were prepared and assessed for their physicochemical properties, secondary structure, and permeation across Caco-2 cells. RESULTS: Lysozyme was found to be substantially bound onto negatively charged vesicles via electrostatic interaction as evidenced by zeta potential measurements regardless of cholesterol content. In contrast, the size of phospholipid vesicle-bound lysozyme became larger with the increasing cholesterol content. The secondary structure of vesicle-bound lysozyme examined by FTIR was unchanged compared to that in buffer solution. The apparent permeability of vesicle-bound lysozyme across Caco-2 cells monolayer was significantly enhanced with a size dependent manner compared to that of solution. CONCLUSION: The permeation across Caco-2 cell monolayers of phospholipid vesicle-bound lysozyme was demonstrated to be significantly enhanced with a size-dependent manner.


Subject(s)
Intestinal Absorption , Muramidase/administration & dosage , Phospholipids/chemistry , Caco-2 Cells , Humans , Muramidase/pharmacokinetics , Particle Size , Permeability , Spectroscopy, Fourier Transform Infrared , Static Electricity
5.
Drug Deliv ; 20(1): 1-9, 2013.
Article in English | MEDLINE | ID: mdl-23216416

ABSTRACT

OBJECTIVE: This work has aimed to develop methotrexate-conjugated pectin nanoparticle for delivering a cytotoxic drug to hepatic cancer cell. METHODS: Methotrexate was conjugated to pectin by carbodiimide chemistry. Nanoparticles of pectin conjugated with methotrexate (MTX) were then fabricated by using ionotropic gelation. The size, shape and surface charge were characterized by dynamic light scattering and microscopic method. Cytotoxicity of MTX-pectin nanoparticle was monitored by MTT assay. RESULTS: Methotrexate-pectin nanoparticle was successfully formulated. Drug release study indicated that MTX-NP exhibited sustained drug release at pH 7.4. Sustained release of methotrexate may enable methotrexate-pectin nanoparticle as a controlled drug delivery system. Cytotoxicity study confirmed the activity of the drug incorporated in nanoparticles. In addition, the cytotoxicity of methotrexate was increased when conjugated to pectin nanoparticles, compared to free methotrexate. CONCLUSIONS: This study verified that pectin can deliver methotrexate to hepatic cancer cell and provide sustained drug delivery. The cytotoxicity of methotrexate was enhanced when methotrexate was conjugated to pectin indicating the improved drug delivery to cancer cell.


Subject(s)
Antimetabolites, Antineoplastic/chemistry , Cytotoxins/chemistry , Drug Delivery Systems/methods , Methotrexate/chemistry , Nanoparticles/chemistry , Pectins/chemistry , Antimetabolites, Antineoplastic/administration & dosage , Cytotoxins/administration & dosage , Hep G2 Cells , Humans , Methotrexate/administration & dosage , Nanoparticles/administration & dosage , Pectins/administration & dosage
6.
Drug Dev Ind Pharm ; 38(6): 718-27, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21999514

ABSTRACT

CONTEXT: One among many attempts to improve oral protein drug delivery was utilizing the colloidal drug carriers particularly liposomes. OBJECTIVE: The purpose was to develop proliposomes of bovine serum albumin (BSA) in the form of granules and delayed-release tablets by using simple tablet manufacturing process. MATERIALS AND METHODS: BSA proliposomes granules were prepared by spraying 7:3 (w/w) -- lecithin:cholesterol solution mixture onto BSA-mannitol granules rotating in a glass coating pan. BSA proliposomes granules were directly compressed into tablets and subsequently coated with Eudragit(®) L100 film. The physical properties and stability in gastrointestinal fluids of delayed-release BSA proliposomes tablets as well as reconstituted liposomes were assessed. RESULTS: The BSA proliposomes tablets disintegrated readily and the obtained reconstituted BSA liposomes exhibited multilamellar vesicles, the size and entrapment efficiency of which were around 2--3 µm and 10--14%, respectively. The delayed-release BSA proliposomes tablets were found to be relatively stable in United States Pharmacopoeia (USP) simulated gastric and intestinal fluids. Increase in amount of BSA in granules resulted in the increase in entrapment efficiency and loading capacity. DISCUSSION: The Fourier transform infrared spectroscopy (FTIR) results indicated increase in α-helix structure of BSA entrapped in liposomes. ³¹P phosphorous nuclear magnetic resonance spectroscopy (³¹P-NMR) spectrum indicated interaction between BSA molecules and phosphoric acid polar groups of bilayers membrane. CONCLUSION: The delayed-release BSA proliposomes tablets developed could completely be reconstituted into liposomes with sufficient resistance to the hostile environment in gastrointestinal tract.


Subject(s)
Drug Delivery Systems , Liposomes/chemistry , Serum Albumin, Bovine/chemistry , Administration, Oral , Animals , Cattle , Delayed-Action Preparations , Drug Compounding/methods , Hydrogen-Ion Concentration , Magnetic Resonance Spectroscopy/methods , Particle Size , Spectroscopy, Fourier Transform Infrared/methods , Tablets/chemistry
7.
J Immunol ; 182(6): 3556-65, 2009 Mar 15.
Article in English | MEDLINE | ID: mdl-19265134

ABSTRACT

Existing therapies for rheumatoid arthritis and other autoimmune diseases are not Ag specific, which increases the likelihood of systemic toxicity. We show that egg phosphatidylcholine liposomes loaded with Ag (OVA or methylated BSA) and a lipophilic NF-kappaB inhibitor (curcumin, quercetin, or Bay11-7082) suppress preexisting immune responses in an Ag-specific manner. We injected loaded liposomes into mice primed with Ag or into mice suffering from Ag-induced inflammatory arthritis. The liposomes targeted APCs in situ, suppressing the cells' responsiveness to NF-kappaB and inducing Ag-specific FoxP3(+) regulatory T cells. This regulatory mechanism suppressed effector T cell responses and the clinical signs of full-blown Ag-induced arthritis. Thus, liposomes encapsulate Ags and NF-kappaB inhibitors stably and efficiently and could be readily adapted to deliver Ags and inhibitors for Ag-specific suppression of other autoimmune and allergic diseases.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Arthritis, Experimental/immunology , Arthritis, Experimental/therapy , Epitopes/immunology , Immunosuppressive Agents/administration & dosage , Liposomes/administration & dosage , Ovalbumin/immunology , Animals , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Experimental/pathology , Curcumin/administration & dosage , Drug Carriers/administration & dosage , Drug Carriers/therapeutic use , Epitopes/administration & dosage , Epitopes/therapeutic use , Immunosuppressive Agents/metabolism , Immunosuppressive Agents/therapeutic use , Injections, Intravenous , Injections, Subcutaneous , Liposomes/therapeutic use , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , NF-kappa B/antagonists & inhibitors , Nitriles/administration & dosage , Ovalbumin/administration & dosage , Ovalbumin/therapeutic use , Quercetin/administration & dosage , Serum Albumin, Bovine/administration & dosage , Serum Albumin, Bovine/immunology , Sulfones/administration & dosage
8.
Bioconjug Chem ; 15(2): 344-8, 2004.
Article in English | MEDLINE | ID: mdl-15025530

ABSTRACT

Recently, the polyion complex (PIC) micelle has been suggested as a promising carrier system for peptide and proteins. However, its utilities are limited by its sensitivity to the environment such as dilution and ionic strength of the solution. In this study, to overcome these obstructions, PIC micelles prepared from an anionic block copolymer, poly(ethylene glycol)-poly(alpha,beta-aspartic acid), and a cationic protein, trypsin, were cross-linked with glutaraldehyde through the Schiff base formation. On the basis of a light scattering technique, the results revealed an efficient resistance of the cross-linked PIC micelle to a high salt concentration, which was a key parameter controlling the structure of the PIC micelles. Moreover, the stability of trypsin after cross-linking was remarkably improved. Evidently, as a bionanoreactor and/or bionanoreservoir, the PIC micelles entrapping protein molecules in the cross-linked core reveal an improved stability, allowing their wide application in the fields of biotechnology and pharmaceutical sciences.


Subject(s)
Cross-Linking Reagents/metabolism , Glutaral/metabolism , Micelles , Nanotechnology/methods , Trypsin/metabolism , Trypsin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...